In a discovery that could hasten treatment for patients with multiple sclerosis (MS), UC San Francisco scientists have discovered a harbinger in the blood of some people who later went on to develop the disease.
Verily’s chief medical officer Amy Abernethy is stepping down
Verily’s chief medical officer and president of product development Amy Abernethy is leaving the company to build a healthcare nonprofit, the company told employees Tuesday